Alder BioPharmaceuticals Executives

Alder BioPharmaceutica Management Team Effectiveness

The company has return on total asset (ROA) of (100.8551) % which means that it has lost $100.8551 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4193) %, meaning that it created substantial loss on money invested by shareholders. Alder BioPharmaceutica's management efficiency ratios could be used to measure how well Alder BioPharmaceutica manages its routine affairs as well as how well it operates its assets and liabilities.

Alder BioPharmaceutica Workforce Comparison

The company has Profit Margin (PM) of 15.82 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of (7.69) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $7.69.

Alder BioPharmaceutica Notable Stakeholders

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Alder BioPharmaceuticals information on this page should be used as a complementary analysis to other Alder BioPharmaceutica's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

If you are still planning to invest in Alder BioPharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alder BioPharmaceutica's history and understand the potential risks before investing.